IntegenX Release: New Web Site MyGenTegra.com Offers Nucleic Acid Storage and Stability Resources and Information

PLEASANTON, CA--(Marketwire - January 05, 2012) - IntegenX Inc. today announced the launch of mygentegra.com, an e-commerce and information web site for researchers concerned about the economic and environmental costs of traditional freezer-based DNA and RNA sample storage. Researchers exploring current concepts and technologies for nucleic acid storage will find peer-reviewed publications, academic posters, videos, and technical information on GenTegra™ products for long-term, room-temperature DNA and RNA storage and recovery.

While significant advances in high-throughput sequencing have been made in recent years, technologies for sample storage and transport have not enjoyed the same breakthroughs. As a result, sample quality and availability are often the major bottlenecks for these systems. IntegenX provides GenTegra DNA and GenTegra RNA as chemical matrices that protect samples from hydrolysis, oxidation, and microbial destruction. Further, the GenTegra products allow scientists to dry, transport, and store their samples safely at convenient temperatures, including room temperature.

As a convenience to new and returning GenTegra product customers, IntegenX offers on-line purchasing on the mygentegra.com site. Customers can place credit card orders for GenTegra DNA and GenTegra RNA kits, tubes, and accessories.

The first 500 visitors to the mygentegra.com web site will be offered the opportunity to request a free sample of a GenTegra RNA or GenTegra DNA nucleic acid storage vial and reagent. Regarding this offer, IntegenX executive vice president Howard Goldstein said, “Room temperature storage of DNA and RNA is a relatively new concept in nucleic acid research that rarely appears in the legacy cloning manuals used by many labs. The limited free sample program is a way to give interested labs an opportunity to validate how they can safely transport DNA or RNA samples at room temperature, save money on freezer storage, and reduce their carbon footprint.”

For additional information, visit www.mygentegra.com.

About IntegenX Inc.
IntegenX, headquartered in Pleasanton, CA, is a privately-held company that leads the emerging field of rapid human DNA identification. IntegenX technology platforms are the result of integration of advanced fluidics and robotic capabilities to produce sample-to-answer products for DNA-based human identity testing and forensics, next generation sequencing, biodefense, and molecular diagnostics applications. The company’s expertise and intellectual property includes its patented MOVe™ valve technology as well as a portfolio of patented DNA and RNA reagents including GenTegra™ for stabilization and storage of purified DNA and RNA, GenPlate® for storage of blood samples, and patent-pending PrepX™ reagent kits for next generation sequencing library preparation. For more information, please visit www.integenx.com.